Washington, 28 Sept 2024: For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia.

 

The twice-a-day pill to be marketed by Bristol Myers Squibb View Details

Related News

• World leaders commit to decisive action on antimicrobial resistance (28-09-2024)

---

• Hoshiarpur Police arrested 6 individuals and seized massive haul of drugs (28-09-2024)

---

• ANTF, Crime Branch Delhi Busted a factory in Hisar Manufacturing Alprazolam, 6 arrested (27-09-2024)

---

• US FDA to Reclassify Hepatitis B Virus Tests as Moderate Risk Devices (27-09-2024)

---

• Pimpri Police Arrest Medical Shop Owner for Selling Fake Cancer Injections, Seizes Rs 3.5 Lakh Worth Drugs (27-09-2024)

---

• Pharma companies say they did not manufacture medicines mentioned in CDSCO Alert (27-09-2024)

---

• IAS Tina Dabi's crackdown on govt doctors (27-09-2024)

---

• 50 New plants to be set up for pharma, medical device manufacturing under PLI Scheme (27-09-2024)

---

• ENTOD Pharma appeals to DCGI over suspension (27-09-2024)

---

• Firms found manufacturing drugs under food licence (26-09-2024)

---